Iran Growth fuels Sinclair Pharma Growth

By John Lee.

International aesthetics company Sinclair Pharma has said it has seen strong growth in Iran.

In an unaudited trading update, the UK-based company said:

Ellansé delivered revenues of £9.6 million compared to £8.1 million in the prior year representing growth of 18% (10% at constant currency). This reflected strong growth in many markets, especially  Spain, Mexico, and Iran.

“Perfectha revenues were £9.4 million against £8.1 million in 2016, growth of 16% (10% at constant currency). Strong demand by distributors in South Korea, Iran and Mexico were the main contributors to this performance.

(Source: Sinclair Pharma)

No comments yet.

Leave a Reply